about
Role of MicroRNAs in innate neuroprotection mechanisms due to preconditioning of the brainSAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cellsA brain-derived MeCP2 complex supports a role for MeCP2 in RNA processingFunctional Profiling of Human MeCP2 by Automated Data Comparison Analysis and Computerized Expression Pathway ModelingMeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.Development of histone deacetylase inhibitors as therapeutics for neurological diseaseMeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5.Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex.Cell-autonomous alterations in dendritic arbor morphology and connectivity induced by overexpression of MeCP2 in Xenopus central neurons in vivoEssential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosisScreening of phage-displayed human liver cDNA library against doxorubicin with drug-immobilized monolithic polyacrylamide cryogel.Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.DNA binding restricts the intrinsic conformational flexibility of methyl CpG binding protein 2 (MeCP2).Complexities of Rett syndrome and MeCP2Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.Perinatal nicotine exposure suppresses PPARγ epigenetically in lung alveolar interstitial fibroblasts.MECP2, a gene associated with Rett syndrome in humans, shows conserved coding regions, independent Alu insertions, and a novel transcript across primate evolutionTLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elementsMECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.The phenotype associated with a large deletion on MECP2.A sibship with duplication of Xq28 inherited from the mother; genomic characterization and clinical outcomes.A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In VitroCreb1-Mecp2-(m)CpG complex transactivates postnatal murine neuronal glucose transporter isoform 3 expressionRegulation of transient receptor potential vanilloid 1 expression in trigeminal ganglion neurons via methyl-CpG binding protein 2 signaling contributes tongue heat sensitivity and inflammatory hyperalgesia in mice.Epigenetics, autism spectrum, and neurodevelopmental disorders.From Function to Phenotype: Impaired DNA Binding and Clustering Correlates with Clinical Severity in Males with Missense Mutations in MECP2.The intervening domain from MeCP2 enhances the DNA affinity of the methyl binding domain and provides an independent DNA interaction site.MeCP2-Related Diseases and Animal Models.MeCP2: structure and function.Genetic diseases: congenital central hypoventilation, Rett, and Prader-Willi syndromes.Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity.Exercise-associated DNA methylation change in skeletal muscle and the importance of imprinted genes: a bioinformatics meta-analysis.Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.Identification of two novel Shank3 transcripts in the developing mouse neocortex.Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands.MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains
P2860
Q27003832-D16D7259-5FB1-43C7-8EEE-B3307E886A9BQ28264289-6AC4AD11-04F8-44DD-BFF0-09006F80483DQ28572490-4123358E-0F81-4FF1-B619-1D58B8024E24Q31097619-D542BAF7-3C32-4142-9DF2-9AA89CC541D3Q33643242-7B2AD5D6-DA46-497D-B658-C04C2A06DB8CQ33670661-13448E99-4CC5-4E7A-B218-29550CAD0F67Q33740585-8EC5A28A-5C1B-4484-9162-281DF89EE40FQ33769492-65B099C8-DD0D-467E-BCB5-C4D1BE0CEF90Q33809732-02465E12-196F-4016-B8A0-26DA839DF39DQ34101214-13B7D9D7-7AEB-4D34-B022-4FFD348AF351Q34112461-C6C37F8F-A0D9-428B-882D-2DE33208860AQ34200572-787239B6-16EC-4A1B-9464-AF8AF8CB2392Q34805635-8912B02C-A889-4637-8576-9A79B00C7E9BQ34818828-723372FF-7B2B-4A8C-BEA4-88A775D4145CQ34988885-76694F29-16D5-4318-B5A7-D6BAB6A6E666Q34998222-732B834D-0E90-4895-A697-62560B07B432Q35080184-76583A75-BF61-4BA2-A1AD-BDAC8DCA849EQ35143592-F914151F-AC9C-4BEC-A17B-45A4BDC1AA3EQ35329148-419FB205-DA86-4C43-8EB4-08C47744F0A4Q35684394-097C91B4-B871-4695-8BB7-1717588CD60DQ35924992-D5692868-873A-4EB3-A627-8761D941752FQ35940880-B3BCC3EB-6657-45D7-84F2-15AB311FB2C4Q36170434-FC427D5F-0557-470A-B784-B20E91A61380Q36311122-ED8BD6A2-0D39-4F93-949F-6E893A013ED7Q36394208-64599F2C-D48E-45EA-A7F1-EE5E2C6B5261Q36699551-9B6C48E8-D5A4-4332-8013-F3506A6D1CD9Q37115281-8DDBEF1F-C3A8-40C9-BCFC-808B98A7F9B7Q37249145-406C88D1-025E-4EFD-BDE1-925C48C8DF98Q37484131-942CA785-568B-4C80-B841-20071FD72BF3Q37615316-3B35FA78-3AA0-4434-972D-C9D4ACB3134EQ37632847-8C519FD6-C4ED-4F47-AFC4-C67C250F03A5Q37843467-577EF1AA-A118-4073-B2E4-9342D2509239Q38110760-B8A7A15E-6FDD-468C-B4CF-8F682EFDD399Q38307079-F579C825-11E3-430F-BCFA-C862CE40EC08Q38396555-1D832DE1-35EE-4CB7-A26F-EDE571D0CEE1Q39023460-A6A487A4-3A73-4BAE-8EF6-E480478C3CBBQ39069727-554344F8-81EB-43C9-9665-972B6ABB1068Q40036997-0638ACCF-BED9-4C7E-BB71-19E433B5E12DQ41228798-762D01A2-9D5B-49F0-8CAC-19D8F61AA6B6Q41860564-8B61DE81-493F-4AFC-8C07-1452B4BF5EF4
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Recent advances in MeCP2 structure and function.
@ast
Recent advances in MeCP2 structure and function.
@en
type
label
Recent advances in MeCP2 structure and function.
@ast
Recent advances in MeCP2 structure and function.
@en
prefLabel
Recent advances in MeCP2 structure and function.
@ast
Recent advances in MeCP2 structure and function.
@en
P2093
P2860
P356
P1476
Recent advances in MeCP2 structure and function.
@en
P2093
Jeffrey C Hansen
Kristopher C Hite
Valerie H Adams
P2860
P304
P356
10.1139/O08-115
P577
2009-02-01T00:00:00Z